FGF2-targeted adenoviral vectors for systemic and local disease

Current Opinion in Molecular Therapeutics

Volumn 1, Issue 5, 1999, Pages 573-579

  Sosnowski, Barbara A ^a   Gu, Dan Ling ^a   D'Andrea, Mark ^a   Doukas, John ^a   Pierce, Glenn F ^a  

^a Selective Genetics Inc   (United States)

Author keywords

Adenovirus; Fibroblast growth factors; Gene therapy; Targeting

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; VIRUS VECTOR;

ADENOVIRUS; CELL REGENERATION; GENE THERAPY; HUMAN; LIGAND BINDING; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; RECEPTOR AFFINITY; REVIEW; SYSTEMIC DISEASE;

ADENOVIRIDAE; ANIMALS; FIBROBLAST GROWTH FACTOR 2; GENE THERAPY; GENETIC VECTORS; HUMANS; LIGANDS; MICE; RATS; RECEPTORS, FIBROBLAST GROWTH FACTOR;

EID: 0032718378     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Ward JH, Kushner JP, Kaplan J: Transferrin receptors of human fibroblasts. Analysis of receptor properties and regulation. J Biol Chem (1982) 208:19-26.
2. Schwartz AL, Fridovich SE, Knowles BB, Lodish HF: Characterization of the asialoglycoprotein receptor in a continuous hepatoma line. J Biol Chem (1981 ) 256:8878-8881.
3. Rorke EA, Jacobberger JW: Transforming growth factor-beta 1 (TGF-β1) enhances apoptosis in human papillomavirus type 16-immortalized human ectocervical epithelial cells. Exp Cell Res (1995) 216:65-72.
4. Rivas CI, Vera JC, Delgado-Lopez F, Heaney ML, Guaiquil VH, Zhang RH, Scher HI, Concha II, Nualart F, Cordon-Cardo C, Golde DW: Expression of granulocyte-macrophage colony-stimulating factor receptors in human prostate cancer. Blood (1998) 91:1037-1043.
5. Sosnowski BA, Gonzalez AM, Chandler LA, Buechler YJ, Pierce GF, Bard A: Targeting DNA to cells with basic fibroblast growth factor (FGF2). J Biol Chem (1996) 52:33647-33653.
6. Hoganson DK, Chandler LA, Fleurbaaij GA, Ying W, Black BE, Doukas J, Pierce GF, Baird A, Sosnowski BA: Targeted delivery of DNA encoding cytotoxic proteins through high-affinity fibroblast growth factor receptors. Hum Gene Ther (1998) 9:2565-2575.
7. Moscatelli D: Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. Implications for mechanisms of bFGF release from pericellular matrix. J Biol Chem (1992) 267:25803-25809.
8. Roghani M, Moscatelli D: Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms. J Biol Chem (1992) 267:22156-22162.
9. Whalen GF, Shing Y, Folkman J: The fate of intravenously administered bFGF and the effect of heparin. Growth Factors (1989) 1:157-164.
10. Lindner V, Reidy MA: Expression of basic fibroblast growth factor and its receptors by smooth muscle cells and endothelium in injured rat arteries. An en face study. Circulation (1993) 75:589-595.
11. Takanami I, Tanaka F, Hashizume T, Kodaira S: Tumor angiogenesis in pulmonary adenocarcinomas: relationship with basic fibroblast growth factor, its receptor, and survival. Neoplasma (1997) 44:295-298.
12. Wang Y, Backer D: Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth. Nature Med(1997) 3:887-893.
13. Chandler LA, Sosnowski BA, Greenlees L, Aukerman SL, Baird A, Pierce GF: Prevalent expression of fibroblast growth factor (FGF) receptors and FGF2 In human tumor cell lines. Int J Cancer (1999) 81:451-458.
14. Werner S, Duan D-SR, de Vries C, Peters KG, Johnson DE, Williams LT: Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities. Mol Cell Biol (1992) 12:82-88.
15. Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, Goldfarb M: Receptor specificity of the fibroblast growth factor family. J Biol Chem (1996) 271:15292-15297.
16. Johnson DE, Williams LT: Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res (1993) 60:1-41.
17. Miki T, Bottaro DP, Fleming TP, Smith CL, Burgess WH, Chan AM-L, Aaronson SA: Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci USA (1992) 89:246-250.
18. Chiou HC, Tangco MV, Levine SM, Robertson D, Kormis K, Wu CH, Wu GY: Enhanced resistance to nuclease degradation of nucleic acids complexed to asialoglyco-protein-polylysine carriers. Nucleic Acids Res (1994) 22:5439-5446.
19. Gospodarowicz D, Cheng J: Heparin protects basic and acidic FGF from inactivation. J Cell Physiol (1986) 128:475-484.
20. Renco M, Quarto N, Morimoto T, Rifkin DB: Nuclear and cytoplasmic localization of different basic fibroblast growth factor species. Cell Regul (1989) 144:108-114.
21. Baldin V, Roman AM, Bosc-Biernei A, Amalric R, Bouche G: Translocation of bFGF to the nucleus is G1 phase cell cycle specific in bovine aortic endothelial cells. EMBO J (1990) 9:1511-1517.
22. Walicke PA, Baird A: Internalization and processing of basic fibroblast growth factor by neurons and astrocytes. J Neurosci (1991) 11:2249-2258.
23. Basilico C, Moscatelli D: The FGF family of growth factors and oncogenes. Adv Cancer Res (1992) 59:115-163.
24. Amalric F, Bouche G, Bonnet H, Brethenou P, Roman AM, Truchet I: Fibroblast growth factor-2 (FGF-2) In the nucleus: translocation process and targets. Biochem Pharmacol (1994) 47:111-115.
25. Komilova E, Sorkina T, Beguinot L, Sorkin A: Lysosomal targeting of epidermal growth factor receptors via a kinase-dependent pathway is mediated by the receptor carboxyl-terminal residues 1022-1123. J Biol Chem (1996) 271:30340-30346.
26. Douglas JT, Rogers BE, Rosenfeld ME, Michael SI, Feng M, Curiel DT: Targeted gene delivery by tropism-modified adenoviral vectors. Nature Biotechnol (1996) 14:1574-1578.
27. Rogers BE, Douglas JT, Sosnowski BA, Ying W, Pierce GF, Buchsbaum DJ, Manna DD, Baird A, Curiel T: Enhanced In vivo gene delivery to human ovarian cancer xenografts utilizing a tropism-modified adenovirus vector. Tumor Targeting (1998) 3:25-31.
28. Goldman CK, Rogers BE, Douglas JT, Sosnowski BA, Ying W, Siegal GP, Baird A, Campain J,A, Curiel DT: Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor. Cancer Res (1997) 57:1447-1451.
29. Reynolds PN, Miller CR, Goldman CK, Doukas J, Sosnowski BA, Rogers BE, Gomez-Navarro J, Pierce GF, Curiel DT, Douglas JT: Targeting adenoviral infection with basic fibroblast growth factor enhances gene delivery to vascular endothelial and smooth muscle cells. Tumor Targeting (1998) 3:156-168.
30. Doukas J, Hoganson DK, Ong M, Ying W, Lacey DL, Baird A, Pierce GF, Sosnowski BA: Retargeted delivery of adenoviral vectors through fibroblast growth factor receptors involves unique cellular pathways. FASEB (1999) 13:1459-1466.
31. Bottaro DP, Rubin JS, Ron D, Finch PW, Florio C, Aaronson SA: Characterization of the receptor for keratinocyte growth factor. Evidence for multiple fibroblast growth factor receptors. J Biol Chem (1990) 265:12767-12770.
32. Rancourt C, Rogers BE, Sosnowski BA, Wang M, Piche A, Pierce GF, Alvarez RD, Siegal GP, Douglas JT, Curiel DT: Basic fibroblast growth factor enhancement of adenovirus-mediated delivery of the herpes simplex virus thymidine kinase gene results in augmented therapeutic benefit in a murine model of ovarian cancer. Clin Cancer Res (1998) 4:2455-2461.
33. Gu D, Gonzalez AM, Printz MA, Doukas J, Ying W, D'Andrea M, Hoganson DK, Curiel DT, Douglas JT, Sosnowski BA, Baird A, Aukerman SL, Pierce GF: Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in mice. Cancer Res (1999) 59:2608-2614.
34. Fang J, Zhu Y, Smiley E, Bonadio J, Rouleau JP, Goldstein SA, McCauley LK, Davidson BL, Roessler BJ: Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci USA (1996) 93:5753-5758.
35. Bonadio J, Smiley E, Patil P, Goldslein S: Localized, direct plasmid gene delivery in vivo: prolonged therapy results In reproducible tissue regeneration. Nature Med (1999) 5:753-759.
36. Pierce GF, Mustoe TA: Pharmacologic enhancement of wound healing. Annu Rev Med (1995) 46:467-481.
37. Pierce GF, Tarpley JE, Tseng J, Bready J, Chang D, Kenney WC, Rudolph R, Robson MC, Van de Berg J, Reid P: Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds. J Clin Invest (1995) 96:1336-1350.
38. Buckley A, Davidson JM, Kamerath CD, Wolt TB, Woodward SC: Sustained release of epidermal growth factor accelerates wound repair. Proc Natl Acad Sci USA (1985) 82:7340-7344.
39. LeGrand EK, Senter LH, Gamelli RL, Kiorpes TC: Evaluation of PDGF-BB, PDGF-AA, bFGF, IL-1, and EGF dose responses in polyvinyl alcohol sponge implants assessed by a rapid histologic method. Growth Factors (1993) 8:315-329.
40. Gartner MH, Benson JD, Caldwell MD: Insulin-like growth factors I and II expression in the healing wound. J Surg Res (1992) 52:389-394.
41. Klagsbum M, Baird A: A dual receptor system is required for basic fibroblast growth factor activity. Cell (1991) 67:229-231.
42. Kwok TT, Sutherland RM: Differences in EGF related radiosensitization of human squamous carcinoma cells with high and low numbers of EGF receptors. Br J Cancer (1991) 64:251-254.
43. Harte MT, Gentry LE: Mutations within subdomain II of the extracellular region of epidermal growth factor receptor selectively alter TGF alpha binding. Arch Biochem Biophys (1995) 322:378-389.
44. Oates TW, Kose KM, Xie JF, Graves DT, Collins JM, Cochran DL: Receptor binding of PDGF-AA and PDGF-BB, and the modulation of PDGF receptors by TGF-beta, in human periodontal ligament cells. J Cell Physiol (1995) 162:359-366.
45. Bachmann MF, Kalinke U, Althage A, Freer G, Burkhart C, Roost HP, Aguet M, Hengartner H, Zinkernagel RM: The role of antibody concentration and avidity in antiviral protection. Science (1997) 276:2024-2027.
46. Kamen BA: Folate and antifolate cell binding and accumulation at physiologic folate concentrations. NCI Monogr (1987) 5:37-39.
47. Rao J, Lahiri J, Isaacs L, Weis RM, Whitesides GM: A trivalent system from vancomycin-D-Ala-D-Ala with higher affinity than avidin-biotin. Science (1998) 280:708-711.